PNIBLOG

Glioblastoma MDNA55 Trial Medicenna

Pacific Neuroscience Institute, the leading enrollment site for the MDNA55 clinical trial for Glioblastoma, is still open and enrolling eligible patients. This innovative phase 2 study is for the minimally invasive convection-enhanced delivery (CED) of a new bioengineered targeted therapeutic, MDNA55, in adults with recurrent or progressive glioblastoma. Read more.

Clinical Trials at Pacific Neuroscience Institute

Pacific Neuroscience Institute opens up two new clinical trials this month, one in Essential Tremor and one in Glioblastoma. Find out more about these new trials as well as the other available open neurological studies.

Pacific Neuroscience Institute Clinical Trials

Find out about the latest clinical trials at Pacific Neuroscience Institute for brain tumor, stroke, movement disorders, and other neurological areas. Call our center at 310-829-8265 to enroll.

Pamela Shavaun Scott displays the 3D brain printing that saved her life

The development of 3D printing, 3D imaging, and HD imaging, has brought the highest quality in imaging modalities to the field of neurosurgery. 3D renders and models can be used in diagnosis and planning stages of treatment and care for conditions such as brain tumors, skull base or pituitary tumors, and facial pain syndromes. Learn more.

Vision is arguably our most important sense. Learn about minimally invasive keyhole surgery options for brain, skull base & pituitary tumors impacting the anterior visual pathways & eye movements.